Alamar Biosciences, Inc.

Research Alamar Biosciences, Inc. (ALMR) on Bullrun: market cap USD 1.92B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerALMR
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryMedical Devices
• CurrencyUSD
• Market capUSD 1.92B
• Financial periodQ1 2026
• RevenueUSD 26.04M
• Net income-USD 21.33M
• Free cash flow-USD 21.13M
• Gross margin55.5%

Valuation Snapshot

latest market cap is USD 1.92B.

About Alamar Biosciences, Inc.

Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers.

Frequently asked questions

What is Alamar Biosciences, Inc.'s market cap?

Alamar Biosciences, Inc.'s market capitalization is USD 1.92B.

What does Alamar Biosciences, Inc. do?

Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers.